September 6 2014 Boston In ALK ROS1 amp EGFR Lung Cancers Clinical trial design and development of highly targeted agents in the molecular oncology era Gideon Blumenthal MD FDA Office of Hematology Oncology Products ID: 513695
Download Presentation The PPT/PDF document "Acquired Resistance Patient Forum" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
